Experimental Exposure Assessment of Ionizable Organic Chemicals in In Vitro Cell-Based Bioassays
- 5 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 33 (7) , 1845-1854
Abstract
Exposure assessment in in vitro cell-based bioassays is challenging for ionizable organic chemicals (IOCs), because they are present as more than one chemical species in the bioassay medium. Furthermore, compared to neutral organic chemicals, their binding to medium proteins and lipids is driven by more complex molecular interactions. Total medium concentrations (Ctotal,medium) and/or freely dissolved medium concentrations (Cfree,medium) were determined for one neutral chemical and 14 IOCs (acids, bases, multifunctional) at concentrations relevant for determination of cytotoxicity and effect. Cfree,medium were measured in two in vitro bioassays at the time of dosing and after 24 h of incubation using solid-phase microextraction (SPME). Cfree,medium were maximally 1.7 times lower than the nominal concentrations (Cnom) for the hydrophilic chemicals (caffeine and lamotrigine). For the organic acids (naproxen, ibuprofen, warfarin and diclofenac), Cfree,medium was by a factor of 4 lower than Cnom at high concentrations but the ratio was much higher at low concentrations, indicating a non-linear binding behavior. The experimental Cfree,medium were also compared with Cfree,medium predicted with a mass balance model accounting for binding to medium proteins and lipids. The mass balance model performed well for five of the test chemicals (within a factor of 10) but it underestimated Cfree,medium by up to a factor of 1200 for chemicals that showed non-linear binding to medium components. These findings emphasize that experimental exposure assessment is required for improved understanding of in vitro toxicity data.Keywords
Funding Information
- European Chemical Industry Council (ECO 36)
This publication has 41 references indexed in Scilit:
- Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor gammaBMC Cardiovascular Disorders, 2013
- Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco‐2 cellsMolecular Nutrition & Food Research, 2012
- In vitro evaluation of new biocompatible coatings for solid-phase microextraction: Implications for drug analysis and in vivo sampling applicationsAnalytica Chimica Acta, 2009
- The importance of plasma protein binding in drug discoveryExpert Opinion on Drug Discovery, 2007
- Generation of a Stable Antioxidant Response Element–Driven Reporter Gene Cell Line and Its Use to Show Redox-Dependent Activation of Nrf2 by Cancer Chemotherapeutic AgentsCancer Research, 2006
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Radical scavenging properties of genisteinFree Radical Biology and Medicine, 2003
- Narcosis Due to Environmental Pollutants in Aquatic Organisms: Residue-Based Toxicity, Mechanisms, and Membrane BurdensCritical Reviews in Toxicology, 1995
- Torasemide Derivatives: New PerspectivesCardiovascular Drug Reviews, 1993
- Spectrophotometric determination of dissociation constants of selected acidic herbicidesJournal of Agricultural and Food Chemistry, 1978